Latest Health News
US Halts Health Aid to Zimbabwe After $367M Deal Collapse
The US is ending health aid programs in Zimbabwe after talks collapsed on a $367 million five-year deal for HIV/AIDS, TB, malaria, and outbreak preparedness. Zimbabwe was to increase its own healthcare funding. This impacts critical public health programs in the nation.
US Child and Teen Obesity Rates Hit Record Highs, CDC Reports
CDC data shows record-high obesity rates among US children and teens, while adult trends slow, based on NHANES surveys over six decades. This highlights ongoing pediatric health crisis amid stabilizing adult rates.
Birth-Dose Hepatitis B Vaccination Rates Drop Over 10 Points in US
A study of 12.4 million US newborns found Hep B birth-dose vaccination fell more than 10 percentage points in two years after prior growth, per JAMA publication. UC San Diego researchers led the analysis.
Nearly 6 in 10 US Women Projected to Have CVD by 2050
American Heart Association projects 60% of US women will have cardiovascular disease by 2050, driven by rising hypertension, obesity, and diabetes. High cholesterol rates may decline, with improvements in diet and activity.
Dentists Prescribe Millions of Risky Clindamycin Antibiotic Yearly
US dentists wrote over 2.3 million clindamycin prescriptions last year despite its black box warning for life-threatening risks. The antibiotic has carried the warning for over 40 years.
FDA Approves New Drug for Primary IgA Nephropathy
FDA granted accelerated approval to an APRIL blocker reducing proteinuria in adults with IgAN at risk of progression. Continued approval pending confirmatory trials on kidney function.
Johnson & Johnson Seeks FDA Approval for First wAIHA Treatment
J&J filed for IMAAVY (nipocalimab) approval as first therapy for warm autoimmune hemolytic anemia, showing rapid hemoglobin response and fatigue improvement in ENERGY trial. No prior FDA-approved options exist for this life-threatening disease.
New FDA Approval for Transplant-Associated Thrombotic Microangiopathy
FDA approved first therapy, a MASP-2 inhibitor, for TA-TMA in stem cell transplant patients aged 2+, with Breakthrough Therapy status. It targets hematopoietic stem cell transplant complications.
Ukraine's Alliance for Public Health Marks 4 Years of War Resilience
Amid four years of war, the Alliance maintained HIV, TB, hepatitis control via mobile clinics, telemedicine, despite damaged facilities. Report highlights systemic resilience and innovation.
Mounjaro Outperforms Rivals in Weight Loss, Boosts Eli Lilly
Eli Lilly's Mounjaro (tirzepatide) shows superior 22% average weight loss vs. 15% for Wegovy, targeting two hormones for better metabolism. It also reduces alcohol intake.
FDA Proposes Custom Treatments for Rare, Hard-to-Treat Diseases
New FDA proposal aims to speed development and approval of personalized treatments for rare diseases. It targets patients lacking standard options.
Canada Recruits US Doctors and Nurses Amid Global Shortages
Facing labor shortages, Canada recruits US healthcare workers, including from Kansas City, as US projects 141,000 physician shortfall by 2038. Missouri and Kansas face regional gaps.